
-
Almeida wins time-trial to take Tour of Switzerland
-
Bublik sees off Medvedev to claim second title on grass in Halle
-
Feyi-Waboso banned for England tour to Argentina
-
US strikes on Iran: what we know
-
Alcaraz crowned king of Queen's for second time
-
US says strikes 'devastated' Iran's nuclear program
-
Bublik sees off Medvedev to claim fifth AFP title in Halle
-
Freed Belarus opposition figure urges Trump to help release all prisoners
-
Wave of syringe attacks mar France's street music festival
-
US intervention 'devastated' Iran's nuclear programme says Pentagon
-
Marc Marquez completes perfect Mugello weekend with Italian MotoGP triumph
-
Vondrousova warms up for Wimbledon with Berlin title
-
India still on top in first Test despite Brook fifty for England
-
Ukraine army chief vows to expand strikes on Russia
-
United behind Iran war effort, Israelis express relief at US bombing
-
Former England fast bowler David Lawrence dead at 61
-
At least three impacts in Israel during Iran missile attacks, 23 hurt
-
Trump says US strikes 'obliterated' Iran nuclear sites
-
Japan's high-tech sunscreens tap into skincare craze
-
Tesla expected to launch long-discussed robotaxi service
-
South Korea counts on shipbuilding to ease US tariff woes
-
Bombing Iran, Trump gambles on force over diplomacy
-
Trump says US attack 'obliterated' Iran nuclear sites
-
Itoje to Valetini: five to watch when the Lions face Australia
-
Wallabies confident but wary of wounded British and irish Lions
-
Utopia and fragile democracy at Art Basel fair
-
Freed Israeli hostage recounts 484-day nightmare in Gaza
-
River Plate frustrated by Monterrey in 0-0 stalemate
-
Panama cuts internet, cell phones in restive province
-
Tens of thousands join pro-Palestinian marches across Europe
-
Coach Penney unsure of return to Super Rugby champions Crusaders
-
Trump says US 'obliterated' Iran nuclear sites, threatens more
-
Olympic chief Kirsty Coventry's steeliness honed by hard knocks
-
Outgoing IOC president Thomas Bach faced mammoth challenges
-
Maro Itoje comes of age with Lions captaincy
-
Trump says US bombs Iran nuclear sites, joining Israeli campaign
-
In New York, Vermeer show reveals art of the love letter
-
Ex-members of secret US abortion group fear return to dark era
-
Trump says US launched 'very successful' attack on Iran nuclear sites
-
Man City squad must be trimmed: Guardiola
-
Minjee Lee grabs four-shot lead at 'brutal' Women's PGA Championship
-
Olympic balloon rises again in Paris
-
Inter Milan, Dortmund claim first wins at Club World Cup
-
South American teams lay down the gauntlet to Europe at Club World Cup
-
Fleetwood grabs PGA Travelers lead as top-ranked stars fade
-
'Lucky' Lamothe hat-trick guides Bordeaux-Begles into Top 14 final
-
Lamothe hat-trick guides Bordeaux-Begles into Top 14 final
-
UK PM Starmer says Kneecap should not perform Glastonbury
-
Inter Milan strike late to beat Urawa Reds at Club World Cup
-
Dortmund stars hide from sun at Club World Cup 'sauna'

US surgeons report longest successful pig-to-human kidney transplant
US surgeons who transplanted a genetically modified pig kidney into a brain-dead patient announced Thursday they had ended their experiment after a record-breaking 61 days.
The latest experimental procedure is part of a growing field of research aimed at advancing cross-species transplants, mainly testing the technique on bodies that have been donated for science.
There are more than 103,000 people waiting for organ transplants in the United States, 88,000 of whom need kidneys.
"We have learned a great deal throughout these past two months of close observation and analysis, and there is great reason to be hopeful for the future," said Robert Montgomery, director of the New York University Langone Transplant Institute, who led the surgery in July.
It was the the fifth so-called xenotransplant performed by Montgomery, who also carried out the world's first genetically modified pig kidney transplant in September 2021.
Tissue collected during the study indicated a mild rejection process had begun, requiring intensification of immunosuppression medication.
By "knocking out" the gene responsible for a biomolecule called alpha-gal -- a prime target for roving human antibodies -- the NYU Langone team were able to stop immediate rejection.
The donor pig in this experiment came from a herd cultivated by Virginia-based biotech company Revivicor.
The herd has also been approved by the Food and Drug Administration as a source of meat for people with hypersensitivity to the alpha-gal molecule, an allergy caused by some tick bites.
These pigs are bred, not cloned, meaning the process can be more easily scaled.
Early xenotransplantation research focused on harvesting organs from primates -- for example, a baboon heart was transplanted into a newborn known as "Baby Fae" in 1984, but she survived only 20 days.
Current efforts focus on pigs, which are thought to be ideal donors for humans because of their organ size, their rapid growth and large litters, and the fact they are already raised as a food source.
In January 2022, surgeons at the University of Maryland Medical School carried out the world's first pig-to-human transplant on a living patient -- this time involving a heart.
He died two months after the milestone, with the presence of porcine cytomegalovirus in the organ later blamed.
Last week, Chinese scientists published a paper showing they had succeeded in hybrid pig-human kidneys in pig embryos, an alternative approach that also has the potential to one day help address organ donation shortages.
But the development raised ethical issues -- especially since some human cells were also found in the pigs' brains, experts said.
E.Aziz--SF-PST